The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s lipid panel testing market report forecasts the lipid panel testing market size to grow to $13.93 Billion by 2027, with a CAGR (compound annual growth rate) of almost 8%.

Learn More On The Lipid Panel Testing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

Lipid Panel Testing Market Size Forecast
The global lipid panel testing market is expected to grow from $9.43 billion in 2022 to $10.28 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global lipid panel testing market size is expected to reach $13.93 billion in 2027 at a CAGR of 7.9%.

North America held the largest lipid panel testing market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Lipid Panel Testing Market Driver ­– Increase In Number Of Cardiovascular And Diabetic Diseases
For example, according to The National Heart, Lung, and Blood Institute, a US-based Institute of the National Institutes of Health, 76,767 people died from cardiovascular disease, which affects the blood arteries that support the brain and related systems, and 339,076 people died from heart disease from March to August 2020. Furthermore, diabetes diagnoses in the United States are expected to reach 37.3 million in 2022, according to the Centres for Disease Control and Prevention (CDC) National Diabetes Statistics Report, a US-based government body. As a result, advancements in cardiovascular and diabetes disorders will propel the lipid panel testing market ahead.

Request for A Sample Of The Global Lipid Panel Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10270&type=smp

Key Lipid Panel Testing Market Trend – Product Innovations
To maintain their market position, major businesses in the lipid panel testing market are focusing on introducing innovative products. For example, in October 2022, Boston Heart Diagnostics, a biotechnology firm based in the United States, published LipoMap, a panel of 33 lipid, lipoprotein, and apolipoprotein assays that provides the most thorough assessments of lipid metabolism commercially available. It identifies curable and reversible lipid abnormalities that cause CVD, enabling for more personalised treatment and follow-up testing.

Lipid Panel Testing Market Segment
1) By Product And Services: Devices, Kits, Services
2) By Prescription Mode: Prescription-Based Testing, OTC-Based Testing
3) By Application: Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hypo-Lipoproteinamia, Tangier Disease, Atherosclerosis, Other Applications
4) By End User: Hospital, Specialty Clinics And Physician Offices, Pathology Laboratories, Diagnostic Clinics, Ambulatory Surgical Centers, Reference Laboratories, Academic And Research Institutes, Other End-Users

Lipid Panel Testing Market Major Players and Strategies
Major players in the lipid panel testing market are Abbott, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., PTS Diagnostics, Quest Diagnostics Incorporated., Alere Inc., EuroMedix, Boston Heart Diagnostics Corporation, Eurofins Scientific, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, and Siemens Healthcare GmbH.

Croda International plc, a UK-based speciality chemicals company, paid an unknown sum for Avanti Polar Lipids in August 2020. Avanti will retain its present name and management team and will join Croda’s Life Sciences division for the rapidly expanding Health Care business. Avanti Polar Lipids Inc. is a pharmaceutical firm established in the United States that provides a wide range of goods, including phospholipids for lipid panel testing.

The Lipid Panel Testing Global Market Report 2023 covers regional data on lipid panel testing market size, lipid panel testing market trends and drivers, opportunities, strategies, and lipid panel testing market competitor analysis. The countries covered in the lipid panel testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

A lipid panel test is a blood test that measures the concentrations of various lipids or fats in the blood. It is used to determine an individual’s risk of acquiring cardiovascular disease.

View More Reports Related To The Lipid Panel Testing Market –
Testing, Inspection, And Certification Global Market Report 2023
Lipid Global Market Report 2023
Testing Software Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: